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Abstract
Objectives
Enteric neural stem cells provide hope of curative treatment for enteric neuropathies. Cur-
rent protocols for their harvesting from humans focus on the generation of ‘neurospheres’
from cultures of dissociated gut tissue. The study aims to better understand the derivation,
generation and composition of enteric neurospheres.
Design
Gut tissue was obtained fromWnt1-Cre;Rosa26Yfp/Yfp transgenic mice (constitutively la-
beled neural crest cells) and paediatric patients. Gut cells were cultured either unsorted
(mixed neural crest/non-neural crest), or following FACS selection into neural crest
(murine-YFP+ve/human-p75+ve) or non-neural crest (YFP-ve/p75-ve) populations. Cul-
tures and resultant neurospheres were characterized using immunolabelling in vitro and fol-
lowing transplantation in vivo.
Results
Cultures of (i) unsorted, (ii) neural crest, and (iii) non-neural crest cell populations generated
neurospheres similar in numbers, size and morphology. Unsorted neurospheres were highly
heterogeneous for neural crest content. Neural crest-derived (YFP+ve/p75+ve) neuro-
spheres contained only neural derivatives (neurons and glia) and were devoid of non-neural
cells (i.e. negative for SMA, c-Kit), with the converse true for non-neural crest-derived
(YFP-ve/p75-ve) ‘neurospheres’. Under differentiation conditions only YFP+ve cells gave
PLOSONE | DOI:10.1371/journal.pone.0119467 March 23, 2015 1 / 18
OPEN ACCESS
Citation: Binder E, Natarajan D, Cooper J, Kronfli R,
Cananzi M, Delalande J-M, et al. (2015) Enteric
Neurospheres Are Not Specific to Neural Crest
Cultures: Implications for Neural Stem Cell
Therapies. PLoS ONE 10(3): e0119467. doi:10.1371/
journal.pone.0119467
Academic Editor: Mirella Dottori, University Of
Melbourne, AUSTRALIA
Received: August 29, 2014
Accepted: January 27, 2015
Published: March 23, 2015
Copyright: © 2015 Binder et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by Great Ormond
Street Hospital Children's Charity, W1018C (NTand
AJB); Great Ormond Street Hospital Children's
Charity, V1222 (NT); and Medical Research Council,
G0800973 (NTand AJB). The funders had no role in
study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
rise to neural derivatives. Both YFP+ve and YFP-ve cells displayed proliferation and spread
upon transplantation in vivo, but YFP-ve cells did not locate or integrate within the host ENS.
Conclusions
Spherical accumulations of cells, so-called ‘neurospheres’ forming in cultures of dissociated
gut contain variable proportions of neural crest-derived cells. If they are to be used for ENS
cell replacement therapy then improved protocols for their generation, including cell selec-
tion, should be sought in order to avoid inadvertent transplantation of non-therapeutic, non-
ENS cells.
Introduction
Severe gut motility disorders result from developmental or acquired abnormalities of the enter-
ic nervous system (ENS) and include aganglionosis in Hirschsprung disease (HSCR), dysgan-
glionosis or neuronal dysfunction seen in chronic intestinal pseudo-obstruction (CIPO) and
immune-mediated neuronal destruction in conditions such as oesophageal achalasia [1–4].
Current definitive treatment of such motility disorders, especially HSCR, is limited to surgical
resection of aganglionic or affected bowel. However, the long-term outcomes of surgery remain
poor [5–9] and novel therapies are required.
Over the last few years, several groups have been working towards developing enteric ner-
vous system (ENS) cell replacement therapy strategies, which have been greatly aided by ad-
vances in the field of neural stem cell biology [10–13]. Here the hypothesis is that stem cells,
capable of generating a sufficient ENS to effect functional recovery when transplanted into the
affected guts of patients with HSCR or other ENS disorders, could improve outcomes following
surgical treatments, or eliminate the need for surgery altogether [12,14,15].
The persistence in foetal and postnatal life of neural stem cells either from CNS [16] or ENS
of mice [17] or human [18] prompted several groups to explore how such cells could be isolat-
ed, cultured and ultimately transplanted into either wild type or aganglionic gut [19–21]. In
order to maximise the efficiency of replenishing the ENS, and given its entire derivation from
neural crest, transplanting a purer population of neural crest-derived cells would seem to be
most favourable [22,23]. This ideal requirement appears to have been satisfied when many of
the above mentioned studies demonstrated that neural crest cells, that retain characteristics of
early ENS progenitors, could be isolated as single cells and cultured to form large cellular aggre-
gates termed neurospheres or neurosphere-like bodies (NLBs). These neurospheres have been
shown to form from mouse gut when cultured in enriched medium [17] and also from human
gut cultures [18,20,24]. They have been regarded as niches for enteric neural crest stem cells
and their formation has been established as an initial method of selecting and enriching for
large numbers of neural crest cells in culture, especially from human gut tissue [18,20,24,25].
Thus, much of the enteric neural stem cell transplantation research in mice so far has been
performed using neurospheres derived from neural crest cells. In mouse this has been refined
by isolating cells using either p75 as a selection marker or from transgenic mouse lines express-
ing GFP under specific ENS promoters such as Ret, EDNRB or activated by Wnt1-Cre
[20,21,25–27]. These authors showed that the transplanted neurosphere-derived cells prolifer-
ated and gave rise to glia and neurons, including several neuronal subtypes, some of which ex-
hibited neurochemical and electrophysiological activity similar to endogenous neurons [21].
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The positive outcomes of these animal studies have underpinned the drive to translate this
research to humans. Towards this, significant progress has been made in the harvesting of ENS
stem cells from human gut. We and other groups have reported the isolation of such cells from
post-natal human full-thickness gut tissue from resection specimens obtained at surgery or
from gut mucosal tissue obtained using conventional, minimally invasive intestinal endoscopic
techniques gut [18–20,24,26]. As opposed to the animal studies, however, no published studies
of human enteric neural stem cells have, to date, utilized specific selection of enteric neural
cells, relying entirely on the generation of neurospheres or NLBs. It is therefore critical that the
nature of enteric neurospheres is carefully elucidated prior to delivery into patients. Hence the
aim of this study is to better understand the generation and composition of neurospheres that
arise in culture of dissociated gut.
Materials and Methods
Animals
Mice carrying a conditional Yfp allele in the Rosa26 locus (MGI:2449038) [28] were mated to
mice expressing Cre recombinase under the control of the Wnt1 promoter/enhancer
(MGI:2386570) [29] to obtainWnt1-Cre;Rosa26Yfp/Yfp offspring that express YFP in NCC [30],
including enteric NCC [31]. All experiments were conducted in accordance with the UK Home
Office regulations for animal experimentation.
Human tissue
Human postnatal mucosal gut biopsy specimens were obtained from children undergoing co-
lonoscopy at Great Ormond Street Hospital (GOSH), London, UK, under ethical approval fol-
lowing informed consent.
Isolation and culture of enteric neural crest stem cells
Gastrointestinal tracts were dissected from embryonic (E12.5-E18.5) and postnatal (P0-P8)
mice. These mouse tissues, and human postnatal gut tissues were dissociated and cultured as
described in the Supplementary Materials (S1 Materials). Neurospheres were generated after a
few days up to two weeks in both cultures using methods described in detail in the Supplemen-
tary Materials (S1 Materials). For wholemount immunostaining, both mouse and human neu-
rospheres were fixed with 4% PFA in PBS for 15 min.
Fluorescence-activated cell sorting (FACS)
Gut tissue fromWnt1-Cre;Rosa26Yfp/Yfp mice was dissociated as above and resuspended in
NSM with 2% fetal bovine serum (FBS, Sigma UK). Cells were sorted with a MoFloXDP cell
sorter (Beckman Coulter). The yellow fluorescent protein positive (YFP+ve) cells were selected
using a 530/40 filter set. Gating parameters were set using cells from wild-type gut and applied
to increase specificity of selection of YFP+ve and YFP negative (YFP-ve) cells. BothYFP+ve
and YFP-ve cell populations were collected. These populations, along with an unsorted cell
population, were plated separately onto fibronectin-coated dishes.
To isolate neural crest and non-neural crest derived cells from human gut samples, p75NTR
conjugated to phycoerythrin (p75PE, Abcam, UK) was used. Cultured cells were dissociated
and incubated with the antibody for 1 hour on ice, washed twice with medium and cells sub-
jected to FACS. For human p75PE positive (p75+ve) cell isolation, cells were selected using a
580/30 filter set. Gating parameters were set using unlabelled cells. As above, both p75+ve and
p75PE negative (p75-ve) cells were collected and plated onto fibronectin coated dishes.
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Transduction of YFP-ve cells using lentivirus
Following FACS to select YFP+ve cells, the YFP-ve population was transduced with a GFP con-
taining lentivirus following a published protocol [32,33]. Lentivirus was added to cultures at
concentrations in the range of 2–5 MOI. Cells were incubated for 24–48 hours to allow cells to
be transduced and for viral particles to self-inactivate.
Transplantation of neurospheres into mouse gut
Neurospheres derived from both YFP+ve and YFP-ve cell cultures were transplanted into the
distal colon of mice, exposed by laparotomy, using a pulled glass needle. The peritoneum was
closed using absorbable sutures and the skin with wound clips, which were removed after 7
days. The gut from transplanted mice was analysed 1–3 months later.
Immunolabelling
Following fixation in 4% PFA, cells were pre-incubated for 1h in blocking solution (BS) com-
prising PBS with 1% BSA, 0.1% Triton X-100 and 0.15% glycine. For neurospheres, blocking
solution contained 1% Triton X-100. Primary and secondary antibodies (Table 1) were applied
in blocking solution. Cells were incubated in primary antibodies for 1–4h at RT and intact neu-
rospheres were incubated for either 3–5h at RT or overnight at 4°C. Following several washings
Table 1.
Primary Antibody Species raised in Dilution Source
Anti-Sox10 Goat 1:300 Santa Cruz Biotechnology
anti-p75 Rabbit 1:300 Santa Cruz Biotechnology
anti-Nestin Mouse 1:50 Millipore
anti-GFP Mouse 1:300 Life Technologies
anti-GFP Rabbit 1:300 Life Technologies
anti-GFP Chicken 1:300 abcam
anti-TuJ1 Mouse 1:500 Covance
anti-TuJ1 Rabbit 1:500 Covance
anti-PGP9.5 Mouse 1:100 abcam
anti-NPY Rabbit 1:200 Santa Cruz Biotechnology
anti-CGRP Rabbit 1:100 Santa Cruz Biotechnology
anti-nNos Rabbit 1:300 Life Technologies
anti-VIP Rabbit 1:300 AbDSerotec
anti-GFAP Rabbit 1:500 Dako
anti-S100 Rabbit 1:500 Dako
anti-SMA Mouse 1:200 Dako
anti-c-Kit Rabbit 1:50 Dako
anti-Ki67 Rabbit 1:500 Novocastra
anti-phospho Histone H3 Rabbit 1:100 Millipore
Secondary Antibody Species raised in Dilution Source
Alexa fluor anti-mouse 488 Goat 1:500 Life Technologies
Alexa fluor anti-rabbit 488 Goat 1:500 Life Technologies
Alexa fluor anti-mouse 568 Goat 1:500 Life Technologies
Alexa fluor anti-rabbit 568 Goat 1:500 Life Technologies
Biotinylated anti-goat Rabbit 1:500 Life Technologies
Streptavidin, Alexa fluor 555 N/A 1:500 Life Technologies
doi:10.1371/journal.pone.0119467.t001
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with PBS + 0.1% Triton X-100 (PBT), cells and neurospheres were incubated in secondary anti-
bodies (Table 1) containing DAPI for 1h at RT. Cells and neurospheres were mounted using ei-
ther Vectashield HardSet (Vector laboratories) or Aqua-Poly/Mount (Polysciences).
Immunolabelled gut samples were analyzed using a Leica SPE1 confocal microscope (Leica
Microsystems). Images are displayed as single sections or as a merge of a number of serial sec-
tions. Figures were compiled using Adobe Photoshop and Illustrator software.
Results
Distribution, selection and proportion of YFP+ve cells in developing
mouse gut
Wnt1-Cre;Rosa26Yfp/Yfp mouse gut was harvested at E12.5, E15.5, E18.5 and P8, cryosectioned
and immunolabelled with anti-GFP antibody (which also labels YFP cells). YFP+ve cells were
located within the outer gut layers, corresponding to the presumptive myenteric plexues of
E12.5 and E15.5 mice (Fig. 1A, 1B) and within the myenteric and submucosal plexus layers of
E18.5 and P8 mice (Fig. 1C, 1D). Guts from these mice were also dissociated and sorted using
FACS for YFP (Fig. 1E). At E12.5, 7.1±0,25% (n = 3) of all cells analysed were YFP+ve. The
highest proportion of YFP+ve cells, 7.68%±0.62% (n = 5), was detected at E15.5. At later
stages (E18.5 and P8) the percentage of YFP+ve cells decreased to 4.13±0.22% (n = 6) and
Fig 1. Distribution, selection and proportion of YFP+ve cells in developing mouse gut. (A-D) Transverse sections ofWnt1-Cre;Rosa26Yfp/Yfpmouse gut
showing distribution of YFP+ve cells at the level of the presumptive myenteric (A-D) and submucosal (C,D arrowheads) plexuses. (E) FACS selection of YFP
+ve cells. Bar graph shows the proportion of YFP+ve cells at selected stages of development. Scale bars = 50μm in A,B and 100μm in C,D.
doi:10.1371/journal.pone.0119467.g001
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1.22±0.38% (n = 4) respectively (Fig. 1A). We used guts from E15.5 mice since they had the
highest proportion of YFP+ve cells.
Neurospheres arise from neural crest and non-neural crest-derived gut
cell populations
In order to study neurosphere generation, we used cultures containing cells from three sources;
Wnt1-Cre;Rosa26Yfp/Yfpmouse gut tissue to segregate, by FACS, (i) YFP+ve neural crest-derived
cells from (ii) YFP-ve non-neural crest-derived cells, while also retaining a pool of (iii) unsorted
gut-derived cells. After being maintained in optimal culture conditions for up to 7 days, neuro-
spheres formed in all three groups of cells (Fig. 2). Unsorted cells gave rise to neurospheres con-
taining both YFP+ve fluorescent cells and YFP-ve cells (Fig. 2A-2D). The neurospheres that
arose from the YFP+ve cells contained only fluorescent cells (Fig. 2E-2H) whereas those from
YFP-ve cells did not contain any fluorescent cells (Fig. 2I-2L). Details of neurospheres
generated were as follows: Average number of neurospheres per well; unsorted = 121±21.7,
YFP+ve = 99±1.8, YFP-ve = 129.8±13.8, N = 4 experiments; Average size of neurospheres per
well: unsorted = 134.6±46μm, YFP+ve = 137.85±50μm YFP-ve = 105±30μm, N = 4 experi-
ments. The morphology of the neurospheres was comparable between the three groups. These
Fig 2. Neurospheres can be generated from YFP+ve, YFP-ve andmixed gut cell populations. Panels show phase contrast images of cultures
containing neurospheres and their YFP fluorescent counterparts. (A-D) Neurospheres from unsorted gut cells contain both YFP+ve and YFP-ve cells
whereas neurospheres derived from YFP+ve sorted cells (E-H) contain only YFP+ve cells. (I-L) Neurospheres from cultures of YFP-ve, non-neural crest cells
do not contain YFP+ve cells. Neurospheres are similar in size and appearance in all cases. Scale bar in G = 200μm (applies to A-C, E-G, I-K) and in
H = 40μm (applies to D, H, L).
doi:10.1371/journal.pone.0119467.g002
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findings suggest that the phenomenon of neurosphere formation in culture is not restricted to
neural crest cells alone.
We next characterised, by immunolabelling, the composition of YFP+ve and YFP-ve neuro-
spheres (Fig. 3). Intact YFP+ve neurospheres contained cells that were positive for the neural
progenitor cell markers p75, Sox10 and Nestin (Fig. 3A-3C), the pan neuronal marker TuJ1
(Fig. 3D), and the glial markers GFAP and S100 (Fig. 3E, 3F). Moreover, some cells were la-
belled with PH3 and Ki67 (Fig. 3G and 3H) indicating that they were undergoing proliferation.
No cells within these neurospheres were positive for either the ICC marker c-Kit or the smooth
muscle actin marker SMA (Fig. 3I and 3J respectively). In contrast, YFP-ve neurospheres were
negative for neural progenitor/neural crest cell markers p75 and Sox10 (i.e. confirming absence
of neural crest-derived cells), although Nestin expressing cells were present (Fig. 4A-4C).
These neurospheres were also negative for the neural and glial cell markers (Fig. 4D-4F). Some
cells within the YFP-ve neurospheres were proliferating as shown by PH3 and Ki67 expression
(Fig. 4G, 4H), and some were immunopositive for c-Kit and SMA (Fig. 4I, 4J respectively).
In order to assess the fates of YFP+ve and YFP-ve cells that comprise mixed population neu-
rospheres, neurospheres generated from unsorted gut cells were cultured under differentiation
conditions for 10 days. Within the mixed cell population, YFP+ve cells exclusively co-immuno-
labelled with a variety of neuronal and neuronal subtype markers, including TuJ1, PGP9.5,
CGRP, NPY, nNOS and VIP (Fig. 5A-5F). They also co-labelled with the glial cell markers
S100 and GFAP (Fig. 5G, 5H). However they did not differentiate into non-neural crest deriva-
tives such as ICC or smooth muscle cells. In contrast, under the same culture conditions, YFP-
ve cells within the mixed population labelled with SMA (Fig. 5I) and c-Kit (Fig. 5J), and not
with any of the markers of neural crest cell derivatives. Both YFP+ve (Fig. 5L, arrows) and
YFP-ve cells (Fig. 5K, 5L arrowheads) expressed the proliferation markers PH3 and Ki67.
Thus, although both neural crest and non-neural crest cell populations are capable of forming
neurospheres, the cell phenotypes that comprise these spheres are different and remain distinct
from each other.
YFP+ve cells associate with host ENS following transplantation
In order to assess the ability of YFP+ve and YFP-ve cells to associate with and integrate into re-
cipient ENS, neurospheres from both sources were transplanted into the distal colon of wild
type mice and analysed 3 to 6 months later. Cells from YFP+ve neurospheres spread out, local-
ised within the myenteric and submucosal plexuses, and integrated within the endogenous
ENS (Fig. 6A). YFP+ve cells co-expressed the neuronal marker TuJ1 and extended extensive
projections that intermingled with the endogenous ENS network (Fig. 6A, arrow). YFP-ve cells
(which were transduced with a GFP containing lentivirus to fluorescently label them for identi-
fication post transplantation) also spread out, but they were separate from each other, and
were not specifically located with or integrated within the ENS layers, and they did not co-ex-
press TuJ1 (Fig. 6B).
Neurospheres from human gut tissues contain neural crest and non-
neural crest-derived cells
Postnatal human gut tissue was dissociated, cultured, ± sorted with p75 to form neurospheres
by day 14 (Fig. 7A). Although the unsorted and sorted neurospheres were similar in appear-
ance and shape to those derived from mouse gut, they were generated in fewer numbers
(Average number of neurospheres per well; unsorted = 23.7±2.7, p75PE+ve = 4.8±0.8, p75PE-
ve = 17.6±4.5 N = 3 experiments) and were slightly smaller (Average size of neurospheres per
well; unsorted = 90.6±13.9μm, p75PE+ve = 79.3±13.7μm p75PE-ve = 103±10.4μm; N = 3
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Fig 3. Immunocytochemical characterization of neurospheres generated from sorted YFP+ve neural
crest-derived cells. YFP+ve neurospheres contain cells positive for neural crest and neural stem/progenitor
markers p75 (A), Sox10 (B) and Nestin (C), the neuronal marker TuJ1 (D), glial markers GFAP (E) and S100
(F), and the proliferation markers PH3 (G) and Ki67 (H, arrows). YFP+ve neurospheres do not contain cells
expressing the ICCmarker c-Kit (I) or the smooth muscle marker, SMA (J). All neurospheres show YFP+ve
cells in green, corresponding markers in red and DAPI (nuclei) in blue. Scale bar = 50μm.
doi:10.1371/journal.pone.0119467.g003
Enteric Neurospheres Are Not Specific to Neural Crest Cultures
PLOS ONE | DOI:10.1371/journal.pone.0119467 March 23, 2015 8 / 18
Fig 4. Characterization of neurospheres generated from YFP-ve, non-neural crest-derived cells.
Neurospheres derived from YFP-ve cells do not contain cells expressing neural crest cell markers p75 (A),
Sox10 (B), neuronal marker TuJ1 (D) or glial markers GFAP (E) or S100 (F). However they do contain cells
expressing Nestin (C), proliferation markers PH3 (G, arrows), Ki67 (H, arrows), ICCmarker c-Kit (I) and
smooth muscle marker SMA (J). All markers in red and DAPI (nuclei) in blue. Scale bar = 50μm.
doi:10.1371/journal.pone.0119467.g004
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Fig 5. Phenotypes of YFP+ve and YFP-ve cells derived frommixed population neurospheres. YFP+ve
cells co-express the pan-neuronal markers TuJ1 (A) and PGP9.5 (B), neuronal subtype markers CGRP (C),
NPY (D), nNOS (E), VIP (F), and the glial cell markers GFAP (G) and S100 (H). YFP-ve cells derived from
mixed population neurospheres immunolabel with non-neural crest lineage markers. YFP-ve cells are
positive for SMA (I) and for c-Kit (J), and some cells co-express the proliferation markers Ki67 (K,
arrowheads) and PH3 (L, arrowheads). Arrows in (L) indicate proliferating YFP+ve cells. DAPI (blue) labels
nuclei. Scale bar = 50μm.
doi:10.1371/journal.pone.0119467.g005
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experiments). Immunohistochemical analysis revealed that unsorted human neurospheres
contained neural crest-derived cells such as ENS progenitors labelled with p75 (Fig. 7B) and
enteric neurons, as shown by labelling with TuJ1 (TuJ1 = 4.1±2.3%) (Fig. 7C), as well as non-
neural crest cell derivatives such as fibroblast-like cells (PDGFRα, Fig. 7D) and smooth muscle
cells (SMA, Fig. 7E). They also contained proliferating cells that labelled with Ki67 (Fig. 7F).
Neural crest and non-neural crest-derived cells were sorted by FACS, based on the expression
of the neural crest-specific marker p75. Following cell culture, the resulting neurospheres gen-
erated from p75-ve cells (Fig. 7G) and p75+ve cells (Fig. 7H) were similar in size and appear-
ance to each other, and to mixed population neurospheres (Fig. 7A). The p75+ve sorted
neurospheres were made up almost exclusively of neurons and glia (TuJ1 = 74.3±25%;
S100 = 23.6±2%). Thus, like mouse gut-derived neurospheres, human neurospheres contain a
heterogeneous mix of neural crest and non-neural crest-derived cells. These can be enriched
for neural crest-derived cells by sorting with a marker such as p75.
Discussion
Current opinion appears to suggest that gut-derived neurospheres represent therapeutic pack-
ages for the treatment of severe gastrointestinal neuropathies. Here we confirm that neuro-
spheres can be generated in cultures of dissociated embryonic and post-natal mouse gut, and
from human gut tissues. However, using cell selection specifically for neural crest cells, we
show that so-called enteric ‘neurospheres’ can also form from non-neural crest populations
and these structures are visually indistinguishable from those generated exclusively from neural
Fig 6. Transplantation of neurospheres into mouse gut. (A) Confocal images of host gut transplanted with YFP+ve neurospheres. YFP+ve cells spread
from the site of transplantation and integrated with the endogenous ENS as shown by TuJ1 immunolabelling (red). (B) Host gut transplanted with YFP-ve
neurospheres. YFP-ve cells, labelled with lentiviral construct expressing GFP (green), did not integrate with the endogenous ENS (red) and were apparent as
individual, isolated cells. Scale bar = 50μm.
doi:10.1371/journal.pone.0119467.g006
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crest cells. As opposed to bona fide neural crest-derived neurospheres that exclusively comprise
neural cells (neurons, glia, ENS progenitors), those derived from non-neural crest cells never
contain such cell types. The latter comprise mesenchymal derivatives (smooth muscle, ICC)
capable of proliferation and survival upon transplantation but fail to integrate with the
recipient ENS.
Our studies confirm the neural crest origin of neurons and glia and suggest that unlike other
postmigratory neural crest cells [34] those present within the intestine are unable to generate
non-neural cell types such as smooth muscle even under differentiation conditions. In differenti-
ation cultures, neural cell types were exclusively generated fromWnt1-Cre;Rosa26Yfp/Yfp-derived
YFP+ve cells and non-neural cells only derived from YFP-ve cells. This is contrary to data from
Bixby et al. that showed that p75+α4+ cells, selected from post-natal gut, were capable of gener-
ating smooth muscle actin positive myofibroblasts in subclonal cultures [35]. In our experi-
ments, neurospheres generated fromp75+ve cells were almost exclusively comprised of neurons
and glia, and did not contain smooth muscle positive cells. The specificity of p75 as a marker of
NCC is further supported by human data from one of the current authors [36] which showed
expression limited to cells in the myenteric and submucosal plexuses. Our findings, consistent
with other studies [37,38] also suggest that nestin expression is not specific to neural crest given
its extensive expression in both neural crest-derived neurospheres and non-neural crest-derived
‘neurospheres’.
Fig 7. Neurospheres derived from postnatal human gut cultures are heterogeneous in composition. (A) Bright field image of neurosphere derived
from human postnatal gut cultured for 2 weeks. Neurospheres contain neural crest-derived cells as shown by expression of the neural crest cell marker p75
(B) and the neuronal marker TuJ1 (C). Neurospheres also contained non-neural crest cell derivatives such as fibroblast-like cells expressing PDGFRα (D),
and muscle cells expressing SMA (E). Proliferating cells are labelled with Ki67 (F). Following FACS sorting based on selection with p75NTR, neurospheres
were generated exclusively from p75-ve (G) and p75+ve cells (H) similar in shape and appearance. DAPI (blue) stains nuclei in B-F. Scale bar = 50μm.
doi:10.1371/journal.pone.0119467.g007
Enteric Neurospheres Are Not Specific to Neural Crest Cultures
PLOS ONE | DOI:10.1371/journal.pone.0119467 March 23, 2015 12 / 18
In our human studies it is possible that the high proportion of non-neural crest cells re-
flected their derivation from the submucosa rather than the myenteric plexus. Becker et al.
working with murine gut, showed that both the ability to generate neurosphere-like bodies
(NLBS) and the proportions of neural crest and non-neural crest cells contained within them
varied according to whether cultures were established from the submucosal or the myenteric
plexus [39]. NLBs from the latter were composed predominantly of neural crest-derived cells
(expression ofWnt1-cre:tdTomato), produced in larger numbers, demonstrated greater prolif-
eration and contained higher proportion of neural derivatives than submucosal NLBs, which
contained higher numbers of non-neural crest cells (CD34+ and smooth muscle-like cells). In
keeping with our findings submucosal NLBs were also seen to form in the absence of neural
crest cells [39]. Although we did not carry out a comparison of neurospheres generated from
human gut mucosal biopsies with those from full thickness biopsies, our murine and human
studies, taken together, suggest that currently accepted protocols to generate enteric neural
crest stem cells without cell selection result in hybrid or neural crest devoid neurospheres.
Hence, consideration in terms of suitability for therapy should be given. We do show, for the
first time, that it is possible to select neural crest cells from human gut mucosal biopsies to gen-
erate bona fide neurospheres containing neural elements.
The ability to select and enrich for neural crest cells may be important for potential cell
transplantation therapies aimed at rescuing or restoring the ENS, which is entirely derived
from the neural crest. However, it is still unclear whether it is beneficial to transplant entire
neurospheres or pure populations of neural crest cells into aganglionic gut. Neurospheres may
represent organized stem cell niches for neural progenitors maintained by differentiated neural
and non-neural cells. Theocharatos et al. [40] suggest that neurospheres may encompass a de-
gree of spatial organization of proliferating cells, with a predominance of dividing cells in the
periphery. However, our current and previous studies [17,20] do not suggest that neurospheres
have a particular organization and confirm that the presence of neural crest cells is not neces-
sary for them to form. It is possible, however, that factors produced by the non-neural crest
cells within mixed population neurospheres may provide paracrine factors necessary for neural
crest-derived cells to survive, proliferate, integrate and form a functional ENS. It is well estab-
lished that during embryonic development of the ENS, key mesenchyme-derived factors, such
as GDNF and endothelin-3, are required by the migrating neural crest population in order to
complete gut colonization and ultimately give rise to the ENS [41–45]. In the adult gut, enteric
neuron survival and neurogenesis appears dependent upon 5-HT4 [46]. Further supporting
this idea, the successful transplantation of mixed population neurospheres into gut has already
been reported. Several groups have shown that neurospheres containing mixed cell popula-
tions, when transplanted into aganglionic gut, gave rise to an ENS network containing neurons,
glial cells and progenitor cells [18,20,24,26]. Lindley et al. [25] demonstrated that mixed neuro-
spheres transplanted into in vitro aganglionic gut regulated functional activity.
Most recently Hetz et al. [24] used human enteric neurospheres generated from postnatal
and adult human intestine for in vivo transplantation into a mouse model of acquired intestinal
hypo/aganglionosis where the intestine was treated prior to transplantation with benzalkonium
chloride (BAC), an established means of inducing denervation of the myenteric plexus. The au-
thors reported functional rescue of the BAC treated gut that had been transplanted with cells
from enteric neurospheres compared to non-transplanted BAC-treated ‘control’ gut. The
mechanism of this recovery, however, was unclear. The authors acknowledge the presence or
generation of non-neural crest cells, which in light of our findings may be a considerable pro-
portion given that most donors were beyond the 5th decade of life where neurogenesis is dimin-
ished [20,47]. Hetz et al. concluded, from their pilot study, that it was not clear whether the
recovery was caused by integration of donor functional neuronal cells or by ‘bystander
Enteric Neurospheres Are Not Specific to Neural Crest Cultures
PLOS ONE | DOI:10.1371/journal.pone.0119467 March 23, 2015 13 / 18
mechanisms’ [24]. Indeed such positive ‘bystander’ roles have been implicated following the
transplantation of mesenchymal, including intestinal myofibroblasts, and other stem cells into
models of intestinal inflammation [48,49]. Hetz et al. showed the presence of transplanted
alpha-SMA positive cells, which could be myofibroblasts. We know from our studies that intes-
tinal myofibroblasts are likely to comprise a sufficient proportion of the neurosphere cell popu-
lation, as shown by both the PDGFRα and SMA positive cells. It has been established that the
endogenous ENS has the inherent ability to regenerate after BAC treatment. Hanani et al.
showed that the endogenous ENS appears capable of regeneration within 7 days of BAC treat-
ment [50]. It is very feasible, therefore, that transplanted human cells in the study by Hetz et al.
may have promoted such regeneration and recovery of endogenous neuronal cells in the recipi-
ent BAC-treated gut rather than functionally integrating themselves [24]. Although this heal-
ing mechanism may be useful to promote ‘healing’ in inflamed gut it will not prove helpful in
HSCR or other conditions characterized by neuronal deficiency or dysfunction.
Even though these mixed neurosphere transplantation experiments appear to have been
successful, at least in terms of ENS rescue, there may be concomitant negative effects from add-
ing mesenchymal cells, including fibroblasts, into recipient gut. These include long-term safety
issues, and excessive scarring or contraction at the site of transplantation. We show that non-
neural crest cells are capable of proliferation and upon transplantation spread out but unlike
neural crest-derived donor cells fail to locate or integrate within the host ENS. We did not as-
certain whether such transplanted cells, upon prolonged follow-up, have malignant potential.
Our own observations from in vivo transplantation of mixed neurospheres show scarring at
the transplantation site (data not shown). Transplantation of other non-neural crest cells may
also carry risks including the inadvertent transfer of immune cells capable of causing graft ver-
sus host disease. Although it could be argued that the numbers of non-neural crest cells within
mixed neurospheres transplanted into recipient gut could be small (1–5% [17]), we show here
that the proportion of non-neural crest cells within neurospheres may actually be considerably
higher, and even exclusive (Fig. 2). Thus the potentially detrimental effects of transplanting
non-neural crest cells into gut may in fact be highly relevant.
Is the transplantation of pure populations of neural crest-derived cells feasible? In the con-
text of transplantation into certain models of ENS disease, the transplantation of pure popula-
tions of neural cells may be possible given that the recipient environment is likely to be
supportive. For example in Ret mutant mice the defect is cell autonomous for neural crest, and
the local gut environment appears to be normal [51]. RETmutations comprise the most com-
mon encountered in human Hirschsprung disease (reviewed in [52]) again suggesting that in a
significant proportion of HSCR patients the recipient gut environment should be favourable
for selected neural crest-derived stem cell transplantation. Hotta et al. demonstrated that cells,
derived from mouse and selected by virtue of their expression of engineered neural crest mark-
ers (EdnrbKik and RetTGM), survived upon transplantation into wild-type and aganglionic gut,
where they migrated and showed evidence of functional integration [21]. Our experiments not
only showed that selection of a pure neural crest population from mouse gut and transplanta-
tion to generate neural cell types in vivo is possible but that a similar concept is practically feasi-
ble from human gut using markers such as p75. Although it is not known whether p75 labels
all neural crest cells it appears to be specific for this cell type. Further work needs to address
whether it optimally and reliably selects proliferating neural progenitors for therapy. The abili-
ty to isolate gut-derived neural crest cells also facilitates the potential of gene therapy once bet-
ter genetic elucidation of enteric neuropathies is established.
Enteric ‘neurospheres’ generated directly from dissociated gut tissue using contemporary
protocols for the purposes of therapy are heterogenous structures, that potentially vary in their
content of neural-crest and non-neural crest populations and can result from pure populations
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of the latter. This heterogeneity is likely to arise from the diverse cell types present within the
gut and by an absence of specific cell type selection prior to the establishment of cell cultures.
Of course in the Wnt1-Cre;YFP transgenic mice neural crest cell selection is facilitated by the
endogenous YFP expression of such cell types. p75 is used in a similar way in the context of
human gut samples. There is a possibility that additional factors, such as the stage of develop-
ment at which the gut is sampled and the medium used to culture the cells, may also influence
the diversity of cell types maintained in cell culture and ultimately present within neuro-
spheres. However, in our unpublished studies we did not find a discernable difference in het-
erogeneity between neurospheres generated from E12.5 to E15.5 unsorted gut cultures.
Furthermore, we compared equivalent cultures maintained in a diversity of media including
the originally used neural crest media [17] and one that we have used in this study and a previ-
ously published investigation. [20]. We did not find differences either in the efficiency of gener-
ating neurospheres, or in the heterogeneity of cells contained within them, between these
media. With this in mind, and given that our ultimate goal is to apply ENS stem cells for
human therapy, we opted to use the simplest media.
This heterogeneous content, however, is not reflected in the visual characteristics of the neu-
rospheres, which appear similar, and suggest that improved or adapted protocols are required
to select or generate ‘optimal’ neurospheres for therapy and reduce potential risks of inadver-
tently transplanting unwanted cell types. Cell selection of neural crest cells from human gut is
feasible but needs further elucidation as to its necessity and practicality. These findings are like-
ly to have implications for enteric neural stem cell therapy.
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